Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Activating Killer-cell Immunoglobulin-like Receptor genes confer risk for Crohn's disease in children and adults of the Western European descent: Findings based on case-control studies.

Samarani S, Mack DR, Bernstein CN, Iannello A, Debbeche O, Jantchou P, Faure C, Deslandres C, Amre DK, Ahmad A.

PLoS One. 2019 Jun 13;14(6):e0217767. doi: 10.1371/journal.pone.0217767. eCollection 2019.

2.

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis.

Iannello A, Rolla S, Maglione A, Ferrero G, Bardina V, Inaudi I, De Mercanti S, Novelli F, D'Antuono L, Cardaropoli S, Todros T, Turrini MV, Cordioli C, Puorro G, Marsili A, Lanzillo R, Brescia Morra V, Cordero F, De Bortoli M, Durelli L, Visconti A, Cutrupi S, Clerico M.

Front Immunol. 2019 Jan 8;9:3075. doi: 10.3389/fimmu.2018.03075. eCollection 2018.

3.

New molecular semi-quantification tool provides reliable microbiological evidence for pulmonary infection.

Yugueros-Marcos J, Barraud O, Iannello A, Ploy MC, Ginocchio C, Rogatcheva M, Alberti-Segui C, Pachot A, Moucadel V, François B; VALIBI study group.

Intensive Care Med. 2018 Dec;44(12):2302-2304. doi: 10.1007/s00134-018-5417-0. Epub 2018 Oct 22. No abstract available.

PMID:
30350171
4.

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.

Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, Zhang L, Iannello A, Mathur N, Jardine KE, Kirn GA, Bell JC, McBurney MW, Raulet DH, Ardolino M.

J Clin Invest. 2018 Oct 1;128(10):4654-4668. doi: 10.1172/JCI99317. Epub 2018 Sep 10.

5.

A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants.

Vachot-Ganée L, Khim N, Iannello A, Legrand E, Kim S, Eam R, Khean C, Ken M, Ashley E, Tun KM, Dhorda M, Nosten F, Souleymane IM, Blein S, Pachot A, Ariey F, Kaiser K, Ménard D.

Malar J. 2018 Apr 24;17(1):175. doi: 10.1186/s12936-018-2329-y.

6.

Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.

Borgoni S, Iannello A, Cutrupi S, Allavena P, D'Incalci M, Novelli F, Cappello P.

Oncoimmunology. 2017 Nov 13;7(2):e1393596. doi: 10.1080/2162402X.2017.1393596. eCollection 2018.

7.

Removing the urinary catheter on post-operative day 2 after robot-assisted laparoscopic radical prostatectomy: a feasibility study from a single high-volume referral centre.

Brassetti A, Proietti F, Cardi A, De Vico A, Iannello A, Pansadoro A, Scapellato A, Riga T, Emiliozzi P, D'Elia G.

J Robot Surg. 2018 Sep;12(3):467-473. doi: 10.1007/s11701-017-0765-2. Epub 2017 Nov 25.

PMID:
29177945
8.

Removing transurethral catheter on postoperative day 2 after robot-assisted laparoscopic radical prostatectomy: towards a new standard?

Brassetti A, Emiliozzi P, Cardi A, DE Vico A, Iannello A, Scapellato A, Riga T, Pansadoro A, D'Elia G.

Minerva Urol Nefrol. 2018 Feb;70(1):102-103. doi: 10.23736/S0393-2249.17.02917-4. Epub 2017 Jun 23. No abstract available.

9.

A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer Cells.

Reineri S, Agati S, Miano V, Sani M, Berchialla P, Ricci L, Iannello A, Coscujuela Tarrero L, Cutrupi S, De Bortoli M.

PLoS One. 2016 Dec 19;11(12):e0168639. doi: 10.1371/journal.pone.0168639. eCollection 2016.

10.

A potentially protective role of IL-18 Binding Protein in HIV-infected Long-Term Non-Progressors.

Iannello A, Samarani S, Allam O, Jenabian MA, Mehraj V, Amre D, Routy JP, Tremblay C, Ahmad A.

Cytokine. 2017 Feb;90:96-99. doi: 10.1016/j.cyto.2016.10.018. Epub 2016 Nov 16.

PMID:
27863336
11.

E2 Regulates Epigenetic Signature on Neuroglobin Enhancer-Promoter in Neuronal Cells.

Guglielmotto M, Reineri S, Iannello A, Ferrero G, Vanzan L, Miano V, Ricci L, Tamagno E, De Bortoli M, Cutrupi S.

Front Cell Neurosci. 2016 Jun 1;10:147. doi: 10.3389/fncel.2016.00147. eCollection 2016.

12.

Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, Chen MB, Krall JA, DeCock J, Zervantonakis IK, Iannello A, Iwamoto Y, Cortez-Retamozo V, Kamm RD, Pittet MJ, Raulet DH, Weinberg RA.

Cancer Discov. 2016 Jun;6(6):630-49. doi: 10.1158/2159-8290.CD-15-1157. Epub 2016 Apr 12.

13.

Immunosurveillance and immunotherapy of tumors by innate immune cells.

Iannello A, Thompson TW, Ardolino M, Marcus A, Raulet DH.

Curr Opin Immunol. 2016 Feb;38:52-8. doi: 10.1016/j.coi.2015.11.001. Epub 2015 Dec 11. Review.

14.

A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cells.

Gowen BG, Chim B, Marceau CD, Greene TT, Burr P, Gonzalez JR, Hesser CR, Dietzen PA, Russell T, Iannello A, Coscoy L, Sentman CL, Carette JE, Muljo SA, Raulet DH.

Elife. 2015 Nov 13;4. pii: e08474. doi: 10.7554/eLife.08474.

15.

Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.

Deng W, Gowen BG, Zhang L, Wang L, Lau S, Iannello A, Xu J, Rovis TL, Xiong N, Raulet DH.

Science. 2015 Apr 3;348(6230):136-9. doi: 10.1126/science.1258867. Epub 2015 Mar 5.

16.

Cytokine therapy reverses NK cell anergy in MHC-deficient tumors.

Ardolino M, Azimi CS, Iannello A, Trevino TN, Horan L, Zhang L, Deng W, Ring AM, Fischer S, Garcia KC, Raulet DH.

J Clin Invest. 2014 Nov;124(11):4781-94. doi: 10.1172/JCI74337. Epub 2014 Oct 20.

17.

Immunosurveillance of senescent cancer cells by natural killer cells.

Iannello A, Raulet DH.

Oncoimmunology. 2014 Jan 1;3(1):e27616. Epub 2014 Jan 6.

18.

Recognition of tumors by the innate immune system and natural killer cells.

Marcus A, Gowen BG, Thompson TW, Iannello A, Ardolino M, Deng W, Wang L, Shifrin N, Raulet DH.

Adv Immunol. 2014;122:91-128. doi: 10.1016/B978-0-12-800267-4.00003-1. Review.

19.

Immune surveillance of unhealthy cells by natural killer cells.

Iannello A, Raulet DH.

Cold Spring Harb Symp Quant Biol. 2013;78:249-57. doi: 10.1101/sqb.2013.78.020255. Epub 2013 Oct 17. Review.

20.

p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells.

Iannello A, Thompson TW, Ardolino M, Lowe SW, Raulet DH.

J Exp Med. 2013 Sep 23;210(10):2057-69. doi: 10.1084/jem.20130783. Epub 2013 Sep 16.

21.

[Interleukin-21: a key cytokine for controlling HIV and other chronic viral infections].

Iannello A, Allam O, Samarani S, Ahmad A.

Med Sci (Paris). 2012 Jun-Jul;28(6-7):605-11. doi: 10.1051/medsci/2012286013. Epub 2012 Jul 16. Review. French.

22.

Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia.

Almalte Z, Samarani S, Iannello A, Debbeche O, Duval M, Infante-Rivard C, Amre DK, Sinnett D, Ahmad A.

Blood. 2011 Aug 4;118(5):1323-8. doi: 10.1182/blood-2010-10-313791. Epub 2011 May 25.

23.

Herpes simplex virus type 1-induced FasL expression in human monocytic cells and its implications for cell death, viral replication, and immune evasion.

Iannello A, Debbeche O, El Arabi R, Samarani S, Hamel D, Rozenberg F, Heveker N, Ahmad A.

Viral Immunol. 2011 Feb;24(1):11-26. doi: 10.1089/vim.2010.0083.

24.

Comment on "HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control".

Iannello A, Samarani S, Ahmad A.

J Immunol. 2010 Nov 15;185(10):5675; author reply 5675. doi: 10.4049/jimmunol.1090103. No abstract available.

25.

IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication.

Iannello A, Boulassel MR, Samarani S, Tremblay C, Toma E, Routy JP, Ahmad A.

J Leukoc Biol. 2010 May;87(5):857-67. doi: 10.1189/jlb.1009701. Epub 2010 Jan 26.

PMID:
20103765
26.

HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication.

Iannello A, Boulassel MR, Samarani S, Tremblay C, Toma E, Routy JP, Ahmad A.

J Infect Dis. 2010 Feb 15;201(4):608-17. doi: 10.1086/650314.

PMID:
20078197
27.

Potential role of IL-18 in the immunopathogenesis of AIDS, HIV-associated lipodystrophy and related clinical conditions.

Iannello A, Samarani S, Debbeche O, Boulassel MR, Tremblay C, Toma E, Routy JP, Ahmad A.

Curr HIV Res. 2010 Mar;8(2):147-64. Review.

PMID:
19954415
28.

Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study.

Iannello A, Boulassel MR, Samarani S, Debbeche O, Tremblay C, Toma E, Routy JP, Ahmad A.

J Immunol. 2010 Jan 1;184(1):114-26. doi: 10.4049/jimmunol.0901967. Epub 2009 Nov 30.

29.

Regulation of phagocytosis in macrophages by neuraminidase 1.

Seyrantepe V, Iannello A, Liang F, Kanshin E, Jayanth P, Samarani S, Szewczuk MR, Ahmad A, Pshezhetsky AV.

J Biol Chem. 2010 Jan 1;285(1):206-15. doi: 10.1074/jbc.M109.055475. Epub 2009 Nov 4.

30.

Role of interleukin-18 in the development and pathogenesis of AIDS.

Iannello A, Samarani S, Debbeche O, Tremblay C, Toma E, Boulassel MR, Routy JP, Ahmad A.

AIDS Rev. 2009 Jul-Sep;11(3):115-25. Review.

PMID:
19654853
31.

[Interleukin-21, new adjuvant for cancer therapy?].

Iannello A, Ahmad A.

Med Sci (Paris). 2009 Apr;25(4):341-3. doi: 10.1051/medsci/2009254341. French. No abstract available.

32.

Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells.

Iannello A, Samarani S, Debbeche O, Ahmad R, Boulassel MR, Tremblay C, Toma E, Routy JP, Ahmad A.

J Virol. 2009 Jun;83(12):5999-6010. doi: 10.1128/JVI.02350-08. Epub 2009 Apr 1.

33.

Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts.

Iannello A, Tremblay C, Routy JP, Boulassel MR, Toma E, Ahmad A.

Viral Immunol. 2008 Sep;21(3):385-8. doi: 10.1089/vim.2008.0025.

PMID:
18788946
34.

Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.

Iannello A, Debbeche O, Samarani S, Ahmad A.

J Leukoc Biol. 2008 Jul;84(1):27-49. doi: 10.1189/jlb.0907649. Epub 2008 Apr 3. Review.

PMID:
18388299
35.

Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.

Iannello A, Debbeche O, Samarani S, Ahmad A.

J Leukoc Biol. 2008 Jul;84(1):1-26. doi: 10.1189/jlb.0907650. Epub 2008 Apr 3. Review.

PMID:
18388298
36.

[Potential role of NK cells in future anti-tumor immunotherapies].

Iannello A, Débbeche O, Samarani S, Sabbagh S, Duval M, Ahmad A.

Med Sci (Paris). 2007 May;23(5):502-8. Review. French.

37.

Contribution of platelet activation to plasma IL-18 concentrations in HIV-infected AIDS patients.

Ahmad R, Iannello A, Samarani S, Morisset R, Toma E, Grosley M, Ahmad A.

AIDS. 2006 Sep 11;20(14):1907-9. No abstract available.

PMID:
16954739
38.

Marsupialization of fistulotomy and fistulectomy wounds improves healing and decreases bleeding: a randomized controlled trial.

Pescatori M, Ayabaca SM, Cafaro D, Iannello A, Magrini S.

Colorectal Dis. 2006 Jan;8(1):11-4.

PMID:
16519632
39.
40.

Viral strategies for evading antiviral cellular immune responses of the host.

Iannello A, Debbeche O, Martin E, Attalah LH, Samarani S, Ahmad A.

J Leukoc Biol. 2006 Jan;79(1):16-35. Epub 2005 Oct 4. Review.

PMID:
16204622
41.

IL-15 and HIV infection: lessons for immunotherapy and vaccination.

Ahmad A, Ahmad R, Iannello A, Toma E, Morisset R, Sindhu ST.

Curr HIV Res. 2005 Jul;3(3):261-70. Review.

PMID:
16022657
42.

Calf pseudohypertrophy in a patient with double neurogenic pathology.

Donato G, Valentino P, Santucci M, Amorosi A, Pittelli M, Maltese L, Volpentesta G, Lavano A, Chirchiglia D, Iannello AN, Ferraro G, Signorelli CD.

Clin Neuropathol. 2000 May-Jun;19(3):142-4.

PMID:
14606588
43.

Morphological variability of pterion in the human skull.

Urzì F, Iannello A, Torrisi A, Foti P, Mortellaro NF, Cavallaro M.

Ital J Anat Embryol. 2003 Apr-Jun;108(2):83-117.

PMID:
14503657
44.

Intracavitary therapy of noninvasive transitional cell carcinomas of the upper urinary tract. A review of the literature.

Bassi P, Iafrate M, Longo F, Iannello A, Mostaccio G, Ingrassia A, Repele M, Tavolini IM.

Urol Int. 2001;67(3):189-94. Review.

PMID:
11598443
45.

[Histopathologic examination of the intervertebral lumbar disk. Evaluation of its usefulness and limitations].

Donato G, Amorosi A, Lavano A, Volpentesta G, Chirchiglia D, Iannello AN, Ferraro G, Aloisi M, Maltese L, Pittelli M, Pardatscher K, Signorelli CD.

Pathologica. 2000 Oct;92(5):327-30. Italian.

PMID:
11198467
46.

[A case of peritoneal tuberculosis. Contribution of mini-endoscopy].

Iannello A, Bianco B, Botti G.

Minerva Ginecol. 1999 Apr;51(4):149-52. Italian.

PMID:
10379153
47.

Telangiectatic osteosarcoma of the skull. A post-Paget case.

Donato G, Lavano A, Volpentesta G, Chirchiglia D, Veraldi A, De Rose F, Iannello AN, Stroscio C, Signorelli CD.

Clin Neuropathol. 1997 Jul-Aug;16(4):201-3.

PMID:
9266145
48.

Organ procurement: experience from a southern Italian region.

Roncone A, Vantaggiato MD, Benvenuto A, Nino A, Iannello A, De Giacomo E, Verre P, Formisani P, Milano GA, Burza F, Caporale S, Cirillo S, Bonofiglio R, Risoli V, Petrassi A.

Transplant Proc. 1996 Feb;28(1):239-41.

PMID:
8644199
49.

[Results of the multicenter study (A.C.O.I. Stapler Study Group) on 420 cases of esophagojejunal and 544 cases of colorectal anastomoses].

Petrassi A, Roncone A, Formisani P, Iannello A.

Ann Ital Chir. 1994 Jan-Feb;65(1):49-58. Italian.

PMID:
7978745
50.

[Treatment of secondary intrahepatic calculosis].

Petrassi A, Iannello A, Formisani P, Guarasci MR.

Ann Ital Chir. 1990 May-Jun;61(3):269-72. Italian.

PMID:
2291506

Supplemental Content

Loading ...
Support Center